Antibodies against heterogeneous nuclear ribonucleoprotein K in patients with cardiac allograft vasculopathy

The presence of anti-hnRNP-K antibodies 4 years after the transplant is statistically associated with CAV disease, regardless of the diagnostic technique. Therefore, prospective detection of these antibodies could be proposed as a helpful biomarker in CAV diagnosis.